Norman Atkins, Jr, Jr, PhD, MBA

Otsuka Pharmaceutical Development & Commercialization, Inc., Princeton, New Jersey

JCP
Safety and Efficacy of Maintenance Treatment with Aripiprazole Once-Monthly in Black/African American Adults With Bipolar I Disorder
Original Research

March 9, 2026

The safety and efficacy of AOM 400 were comparable between Black/African American and non-Black/African American patients with bipolar I disorder
, , , et al
JCP
Original Research

June 1, 2021

Many pharmacologic treatment options are available for insomnia. In this study, the clinical utility of the new hypnotic lemborexant is given clinical perspective via the evidence-based medicine tools of...
, , , et al
PCC
Original Research

June 6, 2019

What do patients consider as unmet needs regarding ADHD treatment? This study examined the impairment experienced in the daily life of adults with ADHD currently treated with pharmacotherapy relative...
, , , et al

Consensus Report on XT Use in Practice

Read the full report
Figure: Graphic promoting Consensus Report on Xanomeline-Trospium; colorful net design shown with JCP logo in lower left.

Subscribe to read
more articles

Subscribe